Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations

Epidermal growth factor receptor (EGFR) mutation is one of the key oncogenic mutations in non-small-cell lung cancer with adenocarcinoma histology. Exon 19 deletions and exon 21 L858R substitutions account for 90%, while EGFR exon 20 insertions constitute 4–10% of EGFR mutations and are the third mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Jia Li, Lim, Sun Min, Lee, Jii Bum, Cho, Byoung Chul, Soo, Ross A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899956/
https://www.ncbi.nlm.nih.gov/pubmed/36756143
http://dx.doi.org/10.1177/17588359221146131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899956/
https://www.ncbi.nlm.nih.gov/pubmed/36756143
http://dx.doi.org/10.1177/17588359221146131

Ejemplares similares